CORALABPharmaceuticals

Coral Laboratories LtdQuarterly Results & Earnings

370.55
-4.99%
Profit Growth YoY-12.70%Latest quarter
Sales Growth YoY-40.96%Latest quarter
Sales CAGR 5Y10.26%5 year compound
Profit CAGR 5Y28.24%5 year compound
📋

Quarterly Performance

YoY Profit Growth-12.70%
🔴 Significant decline
YoY Sales Growth-40.96%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
15.67%
EPS Growth 5Y
28.24%
Interest Coverage
Higher = safer debt servicing
109.00
ROE
13.06%
ROCE
17.44%
💡

Growth Analysis

Coral Laboratories Ltd reported YoY profit growth of -12.70% and revenue growth of -40.96% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 10.26% and profits at 28.24% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.